These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2002545)

  • 41. Human immunodeficiency virus type 1 envelope glycoprotein-specific cytotoxic T lymphocytes in simian-human immunodeficiency virus-infected rhesus monkeys.
    Voss G; Li J; Manson K; Wyand M; Sodroski J; Letvin NL
    Virology; 1995 Apr; 208(2):770-5. PubMed ID: 7747449
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A PCR-derived library of random point mutations within the V3 region of simian immunodeficiency virus.
    Kirchhoff F; Desrosiers RC
    PCR Methods Appl; 1993 May; 2(4):301-4. PubMed ID: 8324503
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Vaccine-induced virus-neutralizing antibodies and cytotoxic T cells do not protect macaques from experimental infection with simian immunodeficiency virus SIVmac32H (J5).
    Hulskotte EG; Geretti AM; Siebelink KH; van Amerongen G; Cranage MP; Rud EW; Norley SG; de Vries P; Osterhaus AD
    J Virol; 1995 Oct; 69(10):6289-96. PubMed ID: 7666529
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.
    Kuwata T; Dehghani H; Brown CR; Plishka R; Buckler-White A; Igarashi T; Mattapallil J; Roederer M; Hirsch VM
    J Virol; 2006 Feb; 80(3):1463-75. PubMed ID: 16415023
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Protection of monkeys by a split vaccine against SIVmac depends upon biological properties of the challenge virus.
    Stahl-Hennig C; Voss G; Dittmer U; Coulibaly C; Petry H; Makoschey B; Cranage MP; Aubertin AM; Lüke W; Hunsmann G
    AIDS; 1993 Jun; 7(6):787-95. PubMed ID: 8363756
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Analysis of simian immunodeficiency virus sequence variation in tissues of rhesus macaques with simian AIDS.
    Kodama T; Mori K; Kawahara T; Ringler DJ; Desrosiers RC
    J Virol; 1993 Nov; 67(11):6522-34. PubMed ID: 8411355
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef.
    Kim EY; Busch M; Abel K; Fritts L; Bustamante P; Stanton J; Lu D; Wu S; Glowczwskie J; Rourke T; Bogdan D; Piatak M; Lifson JD; Desrosiers RC; Wolinsky S; Miller CJ
    J Virol; 2005 Apr; 79(8):4886-95. PubMed ID: 15795274
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Construction and in vitro properties of SIVmac mutants with deletions in "nonessential" genes.
    Gibbs JS; Regier DA; Desrosiers RC
    AIDS Res Hum Retroviruses; 1994 May; 10(5):607-16. PubMed ID: 7917522
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
    Silvera P; Flanagan B; Kent K; Rud E; Powell C; Corcoran T; Bruck C; Thiriart C; Haigwood NL; Stott EJ
    AIDS Res Hum Retroviruses; 1994 Oct; 10(10):1295-304. PubMed ID: 7848685
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glycosylation of gp41 of simian immunodeficiency virus shields epitopes that can be targets for neutralizing antibodies.
    Yuste E; Bixby J; Lifson J; Sato S; Johnson W; Desrosiers R
    J Virol; 2008 Dec; 82(24):12472-86. PubMed ID: 18829751
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of vivo of genetic variability of simian immunodeficiency virus.
    Baier M; Dittmar MT; Cichutek K; Kurth R
    Proc Natl Acad Sci U S A; 1991 Sep; 88(18):8126-30. PubMed ID: 1896460
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Simian immunodeficiency virus DNA vaccine trial in macaques.
    Robinson HL; Lu S; Mustafa F; Johnson E; Santoro JC; Arthos J; Winsink J; Mullins JI; Montefiori D; Yasutomi Y
    Ann N Y Acad Sci; 1995 Nov; 772():209-11. PubMed ID: 8546394
    [No Abstract]   [Full Text] [Related]  

  • 56. Shortening of the symptom-free period in rhesus macaques is associated with decreasing nonsynonymous variation in the env variable regions of simian immunodeficiency virus SIVsm during passage.
    Valli PJ; Lukashov VV; Heeney JL; Goudsmit J
    J Virol; 1998 Sep; 72(9):7494-500. PubMed ID: 9696846
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys.
    Du Z; Lang SM; Sasseville VG; Lackner AA; Ilyinskii PO; Daniel MD; Jung JU; Desrosiers RC
    Cell; 1995 Aug; 82(4):665-74. PubMed ID: 7664345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Engineered CD4- and CXCR4-using simian immunodeficiency virus from African green monkeys is neutralization sensitive and replicates in nonstimulated lymphocytes.
    König RR; Flory E; Steidl S; Neumann J; Coulibaly C; Holznagel E; Holzammer S; Norley S; Cichutek K
    J Virol; 2002 Nov; 76(21):10627-36. PubMed ID: 12368305
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evidence for the cooperation of gp120 amino acids 322 and 448 in SIVmac entry.
    Morrison HG; Kirchhoff F; Desrosiers RC
    Virology; 1993 Jul; 195(1):167-74. PubMed ID: 8317093
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The "V3" domain is a determinant of simian immunodeficiency virus cell tropism.
    Kirchhoff F; Mori K; Desrosiers RC
    J Virol; 1994 Jun; 68(6):3682-92. PubMed ID: 8189506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.